Drugs / Tripterygium glycosides
Tripterygium glycosides
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02044952 | Jan 2014 → May 2016 | Crohn disease | Zhu Weiming | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01820247 | Dec 2012 → Sep 2013 | Crohn disease | Zhu Weiming | Unknown | No outcome recorded |
| — | NCT00935389 | Apr 2009 → Apr 2011 | lupus nephritis, proteinuria | Nanjing University School of Medicine | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04066803 Background | Aug 2018 → Jul 2020 | rheumatoid arthritis | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tripterygium glycosides | “including Leflunomide，Hydroxychloroquine,Sulfasalazine,Azathioprine,Tripterygium glycosides and Total glucosides of paeony” NCT04066803 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Tripterygium Glycosides(T2) is a chloroform/methanol extract Tripterygium wilfordii Hook F (TWHF), the traditional Chinese medicine” NCT01820247 ↗ |
| Route | Oral | “tripterygium glycosides: 2mg/kg/d, oral” NCT02044952 ↗ |